Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy
Clinical trial NCT04418024 · WITHDRAWN
Trial details
- NCT number
- NCT04418024
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-21
- Primary completion
- 2024-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.